Experimental group 2 (interval medication):Interval use of montmorillonite powder

2 trials

Sponsors

Changzhou Cancer (Fourth People's) Hospital, Changzhou Cancer Hospital

Conditions

Malignant tumorMalignant tumors

Phase 4

Clinical study on the interaction between montmorillonite powder and apatinib mesylate tablets

Active, not recruitingChiCTR2500101783

Changzhou Cancer HospitalMalignant tumors

Start: 2025-04-29Updated: 2025-05-05

Unknown Phase

Randomized, controlled, open label clinical study on the pharmacokinetic interaction between montmorillonite powder and apatinib mesylate tablets in human

Active, not recruitingChiCTR2500101210

Changzhou Cancer (Fourth People's) HospitalMalignant tumor

Start: 2025-04-25Updated: 2025-04-28